Trademark Overview
On Thursday, September 5, 2024, a trademark application was filed for CHARTING A PROVEN PATH IN NEUROPSYCHIATRY with the United States Patent and Trademark Office. The USPTO has given the CHARTING A PROVEN PATH IN NEUROPSYCHIATRY trademark a serial number of 98735773. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 5, 2024. This trademark is owned by Seaport Therapeutics, Inc.. The CHARTING A PROVEN PATH IN NEUROPSYCHIATRY trademark is filed in the Advertising, Business and Retail Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases
commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields
research and development in the pharmaceutical and biotechnology fields